Judge Rejects Prior Restraint For Tylenol Ads Ahead Of 'Bellwether' Trial
This article was originally published in The Tan Sheet
J&J/McNeil may continue to advertise the Tylenol line ahead of the first case in multi-district litigation claiming use of the products as labeled is linked to liver damage, says a federal judge. The plaintiff asked the court to prohibit the firm from advertising that could taint the juror pool ahead of the fall trial.
Register for our free email digests: